Back
SPDR® Kensho Final Frontiers ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
60
ROKT
SPDR® Kensho Final Frontiers ETF
Last Price:
44.65
Seasonality Move:
-1.53%
Sell
35
PTCT
PTC Therapeutics
Last Price:
31.23
Seasonality Move:
8.27%
Buy
60
SPDR® Kensho Final Frontiers ETF (ROKT)
is a Buy
Is SPDR® Kensho Final Frontiers ETF a Buy, Sell or Hold?
- The current SPDR® Kensho Final Frontiers ETF [ROKT] share price is $44.65. The Score for ROKT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ROKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.58. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ROKT Stock Price Chart
What is SPDR® Kensho Final Frontiers ETF's stock price today?
-
The SPDR® Kensho Final Frontiers ETF share price today is $44.65
The current trend is relatively stagnant and ROKT is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
ROKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 48.34 | Sell |
Chaikin Money Flow: | 47 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.53 - 45.23) | Sell |
Bollinger Bands (100): | (43.17 - 45.07) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 34.74 | Sell |
Chaikin Money Flow: | 26543 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.49 - 37.71) | Sell |
Bollinger Bands (100): | (26.63 - 35.17) | Sell |
ROKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.64 | Buy |
20-day SMA: | 44.83 | Sell |
50-day SMA: | 44.6 | Buy |
200-day SMA: | 42.71 | Buy |
8-day EMA: | 44.65 | Sell |
20-day EMA: | 44.75 | Sell |
50-day EMA: | 44.59 | Buy |
200-day EMA: | 43.28 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.57 | Sell |
20-day SMA: | 36.04 | Sell |
50-day SMA: | 33.78 | Sell |
200-day SMA: | 27.65 | Buy |
8-day EMA: | 34.28 | Sell |
20-day EMA: | 35.15 | Sell |
50-day EMA: | 33.95 | Sell |
200-day EMA: | 31.82 | Sell |
SPDR® Kensho Final Frontiers ETF Earnings Growth & ROKT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
SPDR® Kensho Final Frontiers ETF Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |